Tapewire

NYSE · USD

CSW

CSW INDUSTRIALS, INC.

Export transactions ↓
Tapewire entity
3917
SEC CIK
0001624794
Parsed reports
426

Last 12 months

Inside the activity.

1 purchase rows · 23 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202505
Jan 202602
Feb 202602
Mar 202611
Apr 202603
May 202602
Jun 202601
Jul 202601
Aug 202603
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 03, 2022 Filed Oct 4, 2022 20:06 UTC
Sullivan DonEVP, GM Contractor Solutions
Tax withholdingCommon Stock 1,345 $119.80 $161,131.00
Disclosure

SEC source: 0001624794-22-000079 · wf-form4_166491398201564.xml · nonDerivative · entry 2

Sullivan Don · CIK 0001663176 · EVP, GM Contractor Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,687

Read SEC document
October 03, 2022 Filed Oct 4, 2022 20:06 UTC
Sullivan DonEVP, GM Contractor Solutions
GrantCommon Stock 4,552 $0.00 $0.00
Disclosure

SEC source: 0001624794-22-000079 · wf-form4_166491398201564.xml · nonDerivative · entry 1

Sullivan Don · CIK 0001663176 · EVP, GM Contractor Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,032

F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares vest ratably over a three-year period on each annual anniversary of the grant.

Read SEC document
September 15, 2022 Filed Sep 15, 2022 22:45 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 1,200 $124.86 $149,832.00
Disclosure

SEC source: 0001624794-22-000078 · wf-form4_166328189553071.xml · nonDerivative · entry 2

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,920

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 15, 2019.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.43 to $125.37, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 15, 2022 Filed Sep 15, 2022 22:45 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 800 $126.42 $101,136.00
Disclosure

SEC source: 0001624794-22-000078 · wf-form4_166328189553071.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,120

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 15, 2019.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.06 to $126.80, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 30, 2022 Filed Aug 31, 2022 20:05 UTC GrantCommon Stock 783 $0.00 $0.00
Disclosure

SEC source: 0001624794-22-000071 · wf-form4_166197629397802.xml · nonDerivative · entry 1

Griffin Bobby · CIK 0001896568 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,481

F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the first anniversary of the grant.

Read SEC document
August 30, 2022 Filed Aug 31, 2022 16:06 UTC GrantCommon Stock 783 $0.00 $0.00
Disclosure

SEC source: 0001624794-22-000074 · wf-form4_166197637104462.xml · nonDerivative · entry 1

Sweezey Jay Kent · CIK 0001691674 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,759

F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the first anniversary of the grant.

Read SEC document
August 30, 2022 Filed Aug 31, 2022 16:05 UTC GrantCommon Stock 783 $0.00 $0.00
Disclosure

SEC source: 0001624794-22-000072 · wf-form4_166197633447967.xml · nonDerivative · entry 1

Swartz Robert M · CIK 0001413221 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,952

F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the first anniversary of the grant.

Read SEC document
August 30, 2022 Filed Aug 31, 2022 20:07 UTC GrantCommon Stock 783 $0.00 $0.00
Disclosure

SEC source: 0001624794-22-000077 · wf-form4_166197643623711.xml · nonDerivative · entry 1

GAMBRELL MICHAEL R · CIK 0001277031 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,951

F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the first anniversary of the grant.

Read SEC document
August 30, 2022 Filed Aug 31, 2022 20:06 UTC GrantCommon Stock 783 $0.00 $0.00
Disclosure

SEC source: 0001624794-22-000073 · wf-form4_166197635297516.xml · nonDerivative · entry 1

JOHNSTON TERRY L · CIK 0001565364 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,525

F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the first anniversary of the grant.

Read SEC document
August 30, 2022 Filed Aug 31, 2022 20:07 UTC GrantCommon Stock 783 $0.00 $0.00
Disclosure

SEC source: 0001624794-22-000076 · wf-form4_166197640713177.xml · nonDerivative · entry 1

LIVINGSTONE LINDA A. · CIK 0001652531 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,951

F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the first anniversary of the grant.

Read SEC document
August 30, 2022 Filed Aug 31, 2022 20:06 UTC GrantCommon Stock 783 $0.00 $0.00
Disclosure

SEC source: 0001624794-22-000075 · wf-form4_166197638859286.xml · nonDerivative · entry 1

Motsenbocker Anne · CIK 0001904253 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 783

F1 · price: Represents shares of restricted common stock granted to the reporting person pursuant to the issuer's Equity and Incentive Compensation Plan. The shares cliff vest on the first anniversary of the grant.

Read SEC document
August 24, 2022 Filed Aug 25, 2022 21:06 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 4,207 $133.42 $561,297.94
Disclosure

SEC source: 0001624794-22-000066 · wf-form4_166146153012866.xml · nonDerivative · entry 5

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · JBA Family Partners, L.P.

Disclosed balance after: 1,500

F5 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.10 to $133.89, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 24, 2022 Filed Aug 25, 2022 21:06 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 2,793 $132.50 $370,072.50
Disclosure

SEC source: 0001624794-22-000066 · wf-form4_166146153012866.xml · nonDerivative · entry 4

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Indirect · JBA Family Partners, L.P.

Disclosed balance after: 5,707

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.07 to $133.05, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 23, 2022 Filed Aug 25, 2022 21:06 UTC
Armes Joseph BDirector · Chairman, President & CEO
Exercise / conversionOption (right to buy) · Derivative 10,800 $0.00 Strike: $25.23 $0.00
Disclosure

SEC source: 0001624794-22-000066 · wf-form4_166146153012866.xml · derivative · entry 6

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,800 shares

Expires 2024-08-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects the broker-assisted cashless exercise and sale of non qualified stock options.

Read SEC document
August 23, 2022 Filed Aug 25, 2022 21:06 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 2,804 $132.63 $371,894.52
Disclosure

SEC source: 0001624794-22-000066 · wf-form4_166146153012866.xml · nonDerivative · entry 3

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,920

F1 · kind: Reflects the broker-assisted cashless exercise and sale of non qualified stock options.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.50 to $132.80, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 23, 2022 Filed Aug 25, 2022 21:06 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 7,996 $133.23 $1,065,307.08
Disclosure

SEC source: 0001624794-22-000066 · wf-form4_166146153012866.xml · nonDerivative · entry 2

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,724

F1 · kind: Reflects the broker-assisted cashless exercise and sale of non qualified stock options.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.81 to $133.80, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 23, 2022 Filed Aug 25, 2022 21:06 UTC
Armes Joseph BDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 10,800 $25.23 $272,484.00
Disclosure

SEC source: 0001624794-22-000066 · wf-form4_166146153012866.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,720

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Reflects the broker-assisted cashless exercise and sale of non qualified stock options.

Read SEC document
August 15, 2022 Filed Aug 15, 2022 22:09 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 700 $143.29 $100,303.00
Disclosure

SEC source: 0001624794-22-000065 · wf-form4_166059850754640.xml · nonDerivative · entry 2

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,920

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 15, 2019.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.13 to $143.70, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 15, 2022 Filed Aug 15, 2022 22:09 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 1,300 $142.42 $185,146.00
Disclosure

SEC source: 0001624794-22-000065 · wf-form4_166059850754640.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,620

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 15, 2019.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.98 to $142.87, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 09, 2022 Filed Aug 9, 2022 20:46 UTC
Alverson LukeSVP, GC & Secretary
GiftCommon Stock 600 $0.00 $0.00
Disclosure

SEC source: 0001624794-22-000063 · wf-form4_166007796652635.xml · nonDerivative · entry 1

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,964

F1 · kind: Represents shares donated by the Reporting Person to a charitable donor advised fund.

Read SEC document
August 09, 2022 Filed Aug 9, 2022 20:48 UTC
Armes Joseph BDirector · Chairman, President & CEO
GiftCommon Stock 1,776 $0.00 $0.00
Disclosure

SEC source: 0001624794-22-000064 · wf-form4_166007808596117.xml · nonDerivative · entry 4

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,920

F5 · kind: Represents shares donated by the Reporting Person to a charitable donor advised fund.

Read SEC document
August 08, 2022 Filed Aug 9, 2022 20:48 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 1,300 $122.28 $158,964.00
Disclosure

SEC source: 0001624794-22-000064 · wf-form4_166007808596117.xml · nonDerivative · entry 3

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 62,696

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 15, 2019.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.78 to $122.75, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 08, 2022 Filed Aug 9, 2022 20:48 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 814 $120.61 $98,176.54
Disclosure

SEC source: 0001624794-22-000064 · wf-form4_166007808596117.xml · nonDerivative · entry 2

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,996

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 15, 2019.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.37 to $121.19, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 05, 2022 Filed Aug 9, 2022 20:48 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 750 $120.05 $90,037.50
Disclosure

SEC source: 0001624794-22-000064 · wf-form4_166007808596117.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,810

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 15, 2019.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.15, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 02, 2022 Filed Aug 2, 2022 21:13 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 563 $120.14 $67,638.82
Disclosure

SEC source: 0001624794-22-000053 · wf-form4_165947481257378.xml · nonDerivative · entry 3

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,560

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 15, 2019.

F4 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 01, 2022 Filed Aug 2, 2022 21:13 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 6,073 $120.44 $731,432.12
Disclosure

SEC source: 0001624794-22-000053 · wf-form4_165947481257378.xml · nonDerivative · entry 2

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,123

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 15, 2019.

F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.97, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
July 29, 2022 Filed Aug 2, 2022 21:13 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 500 $120.10 $60,050.00
Disclosure

SEC source: 0001624794-22-000053 · wf-form4_165947481257378.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,196

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 15, 2019.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.01 to $120.08, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 09, 2022 Filed Apr 11, 2022 20:49 UTC
Alverson LukeSVP, GC & Secretary
GrantPerformance Rights · Derivative 1,500 $0.00 $0.00
Disclosure

SEC source: 0001624794-22-000023 · wf-form4_164971017807203.xml · derivative · entry 1

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,908

Underlying: Common Stock · 1,500 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2022 and ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2022 and ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2022 and ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

Read SEC document
April 09, 2022 Filed Apr 11, 2022 20:50 UTC
Armes Joseph BDirector · Chairman, President & CEO
GrantPerformance Rights · Derivative 7,581 $0.00 $0.00
Disclosure

SEC source: 0001624794-22-000025 · wf-form4_164971022261010.xml · derivative · entry 3

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,068

Underlying: Common Stock · 7,581 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2022 and ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2022 and ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2022 and ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

Read SEC document
April 09, 2022 Filed Apr 11, 2022 20:50 UTC GrantPerformance Rights · Derivative 2,948 $0.00 $0.00
Disclosure

SEC source: 0001624794-22-000024 · wf-form4_164971019754333.xml · derivative · entry 1

Perry James E · CIK 0001323684 · EVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,877

Underlying: Common Stock · 2,948 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2022 and ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2022 and ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2022 and ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

Read SEC document
April 09, 2022 Filed Apr 11, 2022 20:51 UTC
Sullivan DonEVP, GM Contractor Solutions
GrantPerformance Rights · Derivative 3,369 $0.00 $0.00
Disclosure

SEC source: 0001624794-22-000026 · wf-form4_164971025015238.xml · derivative · entry 1

Sullivan Don · CIK 0001663176 · EVP, GM Contractor Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,343

Underlying: Common Stock · 3,369 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2022 and ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2022 and ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

F1 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vest at a rate between 0% and 200% during a three-year performance cycle beginning on April 1, 2022 and ending on March 31, 2025 based on the issuer's relative total shareholder return in comparison to the total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights may be settled, at the issuer's discretion, in cash or shares of common stock.

Read SEC document
April 06, 2022 Filed Apr 6, 2022 20:43 UTC
Alverson LukeSVP, GC & Secretary
Exercise / conversionPerformance Rights · Derivative 2,572 $0.00 $0.00
Disclosure

SEC source: 0001624794-22-000018 · wf-form4_164927782072410.xml · derivative · entry 3

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,408

Underlying: Common Stock · 2,572 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2022 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with accrued dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2022 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with accrued dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2022 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with accrued dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

Read SEC document
April 06, 2022 Filed Apr 6, 2022 20:43 UTC
Alverson LukeSVP, GC & Secretary
Tax withholdingCommon Stock 2,097 $114.28 $239,645.16
Disclosure

SEC source: 0001624794-22-000018 · wf-form4_164927782072410.xml · nonDerivative · entry 2

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,306

Read SEC document
April 06, 2022 Filed Apr 6, 2022 20:43 UTC
Alverson LukeSVP, GC & Secretary
Exercise / conversionCommon Stock 5,258 $0.00 $0.00
Disclosure

SEC source: 0001624794-22-000018 · wf-form4_164927782072410.xml · nonDerivative · entry 1

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,257

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 06, 2022 Filed Apr 6, 2022 22:02 UTC Amendment
Alverson LukeSVP, GC & Secretary
Exercise / conversionPerformance Rights · Derivative 2,572 $0.00 $0.00
Disclosure

SEC source: 0001624794-22-000021 · wf-form4a_164928255408094.xml · derivative · entry 3

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,408

Underlying: Common Stock · 2,572 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2022 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with accrued dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F2 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2022 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with accrued dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F2 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2022 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with accrued dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

Read SEC document
April 06, 2022 Filed Apr 6, 2022 22:02 UTC Amendment
Alverson LukeSVP, GC & Secretary
Tax withholdingCommon Stock 2,097 $114.28 $239,645.16
Disclosure

SEC source: 0001624794-22-000021 · wf-form4a_164928255408094.xml · nonDerivative · entry 2

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,564

F1 · balance_after: This Amendment to Form 4 does not report a new transaction. This Amendment is being filed solely to correct an inadvertent mathematical error in the sum reported for the Amount of Securities Beneficially Owned following the transactions previously reported in the original Form 4 filed on April 6, 2022.

Read SEC document
April 06, 2022 Filed Apr 6, 2022 22:02 UTC Amendment
Alverson LukeSVP, GC & Secretary
Exercise / conversionCommon Stock 5,258 $0.00 $0.00
Disclosure

SEC source: 0001624794-22-000021 · wf-form4a_164928255408094.xml · nonDerivative · entry 1

Alverson Luke · CIK 0001668461 · SVP, GC & Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,661

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: This Amendment to Form 4 does not report a new transaction. This Amendment is being filed solely to correct an inadvertent mathematical error in the sum reported for the Amount of Securities Beneficially Owned following the transactions previously reported in the original Form 4 filed on April 6, 2022.

Read SEC document
April 06, 2022 Filed Apr 6, 2022 20:44 UTC
Armes Joseph BDirector · Chairman, President & CEO
Exercise / conversionPerformance Rights · Derivative 13,373 $0.00 $0.00
Disclosure

SEC source: 0001624794-22-000020 · wf-form4_164927786947229.xml · derivative · entry 4

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,487

Underlying: Common Stock · 13,373 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2022 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2022 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2022 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

Read SEC document
April 06, 2022 Filed Apr 6, 2022 20:44 UTC
Armes Joseph BDirector · Chairman, President & CEO
Tax withholdingCommon Stock 10,734 $114.28 $1,226,681.52
Disclosure

SEC source: 0001624794-22-000020 · wf-form4_164927786947229.xml · nonDerivative · entry 2

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,696

Read SEC document
April 06, 2022 Filed Apr 6, 2022 20:44 UTC
Armes Joseph BDirector · Chairman, President & CEO
Exercise / conversionCommon Stock 27,286 $0.00 $0.00
Disclosure

SEC source: 0001624794-22-000020 · wf-form4_164927786947229.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 83,430

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 06, 2022 Filed Apr 6, 2022 22:03 UTC Amendment
Sullivan DonEVP, GM Contractor Solutions
Exercise / conversionPerformance Rights · Derivative 3,006 $0.00 $0.00
Disclosure

SEC source: 0001624794-22-000022 · wf-form4a_164928257186886.xml · derivative · entry 3

Sullivan Don · CIK 0001663176 · EVP, GM Contractor Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,974

Underlying: Common Stock · 3,006 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2022 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with accrued dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F2 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2022 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with accrued dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F2 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2022 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with accrued dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

Read SEC document
April 06, 2022 Filed Apr 6, 2022 22:03 UTC Amendment
Sullivan DonEVP, GM Contractor Solutions
Tax withholdingCommon Stock 2,433 $114.28 $278,043.24
Disclosure

SEC source: 0001624794-22-000022 · wf-form4a_164928257186886.xml · nonDerivative · entry 2

Sullivan Don · CIK 0001663176 · EVP, GM Contractor Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,480

F1 · balance_after: This Amendment to Form 4 does not report a new transaction. This Amendment is being filed solely to correct an inadvertent mathematical error in the sum reported for the Amount of Securities Beneficially Owned following the transactions previously reported in the original Form 4 filed on April 6, 2022.

Read SEC document
April 06, 2022 Filed Apr 6, 2022 22:03 UTC Amendment
Sullivan DonEVP, GM Contractor Solutions
Exercise / conversionCommon Stock 6,142 $0.00 $0.00
Disclosure

SEC source: 0001624794-22-000022 · wf-form4a_164928257186886.xml · nonDerivative · entry 1

Sullivan Don · CIK 0001663176 · EVP, GM Contractor Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,913

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: This Amendment to Form 4 does not report a new transaction. This Amendment is being filed solely to correct an inadvertent mathematical error in the sum reported for the Amount of Securities Beneficially Owned following the transactions previously reported in the original Form 4 filed on April 6, 2022.

Read SEC document
April 06, 2022 Filed Apr 6, 2022 20:44 UTC
Sullivan DonEVP, GM Contractor Solutions
Exercise / conversionPerformance Rights · Derivative 3,006 $0.00 $0.00
Disclosure

SEC source: 0001624794-22-000019 · wf-form4_164927783767664.xml · derivative · entry 3

Sullivan Don · CIK 0001663176 · EVP, GM Contractor Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,974

Underlying: Common Stock · 3,006 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2022 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with accrued dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.exercise_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2022 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with accrued dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

F1 · derivative.expiration_date: Each performance right represented a contingent right to receive one share of the issuer's common stock at vesting. The performance rights vested at a rate between 0% and 200% during a three-year performance cycle ending on March 31, 2022 based on the issuer's relative total shareholder return performance among the Russell 2000 Index over the performance cycle. The performance rights, along with accrued dividend equivalent units, vested at 200% of the target award amount and were settled in shares of common stock pursuant to the award agreement terms.

Read SEC document
April 06, 2022 Filed Apr 6, 2022 20:44 UTC
Sullivan DonEVP, GM Contractor Solutions
Tax withholdingCommon Stock 2,433 $114.28 $278,043.24
Disclosure

SEC source: 0001624794-22-000019 · wf-form4_164927783767664.xml · nonDerivative · entry 2

Sullivan Don · CIK 0001663176 · EVP, GM Contractor Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,338

Read SEC document
April 06, 2022 Filed Apr 6, 2022 20:44 UTC
Sullivan DonEVP, GM Contractor Solutions
Exercise / conversionCommon Stock 6,142 $0.00 $0.00
Disclosure

SEC source: 0001624794-22-000019 · wf-form4_164927783767664.xml · nonDerivative · entry 1

Sullivan Don · CIK 0001663176 · EVP, GM Contractor Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,279

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 28, 2022 Filed Feb 28, 2022 22:39 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 3,714 $120.38 $447,091.32
Disclosure

SEC source: 0001624794-22-000017 · wf-form4_164608790897128.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,684

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 15, 2019.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.11 to $120.71, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
January 18, 2022 Filed Jan 21, 2022 16:18 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 286 $120.09 $34,345.74
Disclosure

SEC source: 0001624794-22-000002 · wf-form4_164278191543314.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,398

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 15, 2019.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.32, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 31, 2021 Filed Jan 3, 2022 22:05 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 1,700 $120.25 $204,425.00
Disclosure

SEC source: 0001624794-22-000001 · wf-form4_164124753266582.xml · nonDerivative · entry 2

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,684

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 15, 2019.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.04 to $120.81, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 30, 2021 Filed Jan 3, 2022 22:05 UTC
Armes Joseph BDirector · Chairman, President & CEO
SaleCommon Stock 300 $120.05 $36,015.00
Disclosure

SEC source: 0001624794-22-000001 · wf-form4_164124753266582.xml · nonDerivative · entry 1

Armes Joseph B · CIK 0001413614 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,384

F1 · kind: The transaction reported was effected pursuant to a 10b5-1 trading plan established by the reporting person on August 15, 2019.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.